Drug Profile
Diclofenac/lidocaine - Yung Shin
Alternative Names: Topical VDO; VDOLatest Information Update: 01 Apr 2017
Price :
$50
*
At a glance
- Originator Yung Shin Pharmaceutical
- Class
- Mechanism of Action Cyclophilin inhibitors; Sodium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Herpes labialis
Most Recent Events
- 31 Mar 2017 No recent reports of development identified - Phase-II for Herpes labialis in Taiwan (Topical)
- 01 Jul 2014 Phase-II clinical trials in Herpes labialis in Taiwan (Topical)